Annovis is also seeking fresh capital while working to advance trials for both Alzheimer's and Parkinson's disease drugs.

“Pothead” could one day get a whole new meaning. A new study suggests low doses of THC, the main psychoactive ingredient in ...

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one ...

A once-a-day pill that helps slow down the course of Alzheimer’s disease is a step closer to becoming a reality in a major ...

THC plus a common anti-inflammatory drug show promise.

New research suggests THC’s cognitive drawbacks may be mitigated when combined with a targeted anti-inflammatory drug. Cannabis research has highlighted a scientific paradox. Its best-known ...

Anavex (AVXL) blarcamesine faces uncertain FDA path in early Alzheimer’s; Phase 3 may be needed. Read here a detailed ...

From Science.org. "T3D Therapeutics alleges that contract researchers delivered “medically impossible” results on its candidate drug. In 2023, the drug ...

Every three minutes, someone in the UK is diagnosed with dementia. It is not an easy diagnosis to receive for the patient or ...

In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...

Conventional treatments of Alzheimer's disease, one of the most common forms of dementia, have been largely focused on ...

Alzheimer’s disease has long resisted simple solutions, but a new line of research suggests an unexpected pairing could help keep the condition at bay: a marijuana-derived compound working alongside a ...